 |
|
BellaGel breast implant: 6-Year results of a prospective cohort study
Joon Seok Oh, Jae Hoon Jeong, Yujin Myung, Jeongseok Oh, Shin Hyeok Kang, Eonju Park, Ara Kim, Sa Ik Bang, Chan Yeong Heo
Arch Plast Surg. 2020;47(3):235-241. Published online 2020 May 15 DOI: https://doi.org/10.5999/aps.2019.01858
|
|
Citations to this article as recorded by
 A non-manufacturer-sponsored, retrospective study to assess 2-year safety outcomes of the BellaGel® SmoothFine as compared with its competitors in the context of the first Korean case of a medical device fraud
Sang Eun Nam, Sangdal Lee, Younghye Cho, Jae Hong Kim, Carla Pegoraro
PLOS ONE.2023; 18(2): e0259825. CrossRef Mortality Rate in Breast Implant Surgery: Is an Additional Procedure Worthwhile to Mitigate BIA-ALCL Risk?
Fabio Santanelli di Pompeo, Michail Sorotos, Mark W. Clemens, Guido Paolini, Paolo Anibaldi, Marina Davoli, Giovanni Baglio, Luigi Pinnarelli, Margherita Ferranti, Francesco Cerza, Stefano Domenico Cicala, Guido Firmani
Aesthetic Plastic Surgery.2023; 47(3): 914. CrossRef Current status of breast implant-associated anaplastic large cell lymphoma in South Korea
Eul-Sik Yoon
Journal of the Korean Medical Association.2021; 64(1): 5. CrossRef Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient
Il-Kug Kim, Ki Yong Hong, Choong-kun Lee, Bong Gyu Choi, Hyunjong Shin, Jun Ho Lee, Min Kyoung Kim, Mi Jin Gu, Jung Eun Choi, Tae Gon Kim
Aesthetic Surgery Journal.2021; 41(5): NP214. CrossRef Two international public platforms for the exposure of Archives of Plastic Surgery to worldwide researchers and surgeons: PubMed Central and Crossref
Sun Huh
Archives of Plastic Surgery.2020; 47(5): 377. CrossRef
|